Each vial of 1 ml contains:
Active substances:
relfovetmab*: 2.5 mg
* Relfovetmab is a felinised anti-nerve growth factor (NGF) monoclonal antibody expressed through recombinant techniques in Chinese hamster ovary (CHO) cells.
Excipients:
Qualitative composition of excipients and other constituents
Sucrose
Sodium acetate trihydrate
Poloxamer 188
Acetic acid glacial
L-methionine
Disodium EDTA dihydrate
Water for injections